Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
12/2005
12/29/2005US20050288303 Cyclic protein tyrosine kinase inhibitors
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050288275 New compounds
12/29/2005US20050288233 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS
12/29/2005US20050287617 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/29/2005CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors
12/29/2005CA2570196A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005CA2570170A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005CA2570065A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors
12/29/2005CA2568756A1 Substituted quinazolones as anti-cancer agents
12/28/2005EP1609791A1 Preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-Chloro-2-thienyl)methy]propy]amino]-3H-imidazo[4,5-b]pyridin-3-y]-N-ethyl-2,3-dihydroxycyclopentanecarboxamide
12/28/2005EP1609790A2 Benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/28/2005EP1609789A1 Ureido-pyrazole derivatives and their use as kinase inhibitors
12/28/2005EP1609785A1 C-glycoside derivatives and salts thereof
12/28/2005EP1608643A1 6-sulfonamide quinoline and chromene derivative as androgen receptor antagonists
12/28/2005EP1608639A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
12/28/2005EP1608632A1 Quinazolines useful as modulators of ion channels
12/28/2005EP1608630A1 2, 3, 6-trisubstituted-4-pyrimidone derivatives
12/28/2005EP1608629A1 Benzyl-pyridazinons as reverse transcriptase inhibitors
12/28/2005EP1608623A1 Metal ion chelators and therapeutic use thereof
12/28/2005EP1608619A1 Muscarinic agonists
12/28/2005EP1608375A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
12/28/2005EP1608363A1 Methods for treating inflammatory conditions or inhibiting jnk
12/28/2005EP1608352A1 Polyamine compounds for treating chemokine receptor mediated diseases
12/28/2005EP1608309A2 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
12/28/2005EP1497240A4 Non-heating clay composites for building materials
12/28/2005EP1432415B1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005EP1000932B9 Aromatic ring derivatives
12/28/2005EP0945445B9 1,5-benzodiazepine derivatives
12/28/2005CN1714083A Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
12/28/2005CN1714078A Indoles useful in the treatment of androgen-receptor related diseases
12/28/2005CN1714077A 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy.
12/27/2005US6979742 Process for obtaining enantiomers of thienylazolylalcoxyethanamines
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979692 Triamide-substituted heterobicyclic compounds
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005CA2206799C Small molecule inhibitors of rotamase enzyme activity
12/22/2005WO2005121134A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005WO2005121129A1 Novel propenone derivatives containing aromatic rings, a maufacturing process thereof and a composition containing the same using as an antiinflammatory agent
12/22/2005WO2005121126A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005WO2005121121A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005WO2005121100A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/22/2005WO2005121091A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005WO2005120515A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005WO2005120503A2 N-aryl piperidine compounds for inhibiting hiv infection
12/22/2005WO2005113537A3 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/22/2005WO2005082863A3 1,4 diaryl-dihydropyrimidin-2 ones and their use as a human neutrophil elastase inhibitors
12/22/2005WO2005066151A3 Histone deacetylase inhibitors
12/22/2005US20050283007 adamanolol; 1'-(adamantane-1-carbonyl)-[4,4']bipiperidinyl-1-carboxylic acid [2-hydroxy-3-3-(1H-indol-4-yloxy)-propyl]-isopropyl-amide;human epidermal growth factor receptor antagonist; alpha-helix mimetics of Sur-2 (supressor of Ras); anticarcinogenic agent; breast cancer
12/22/2005US20050282907 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus
12/22/2005US20050282875 Pyrrolidinium derivatives
12/22/2005US20050282862 Aromatic amides
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282847 Oxidizing a 4-substituted-2-thiopyrimidine and reacting the sulfone formed with an alkylcyanamide; both thio and sulfonyl intermediates of 4-substitutedaminopyridines are claimed, e.g., 4,6-dichloro-5-(2-chloro-6-fluorophenyl)-2-methylthiopyrimidine
12/22/2005US20050282828 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
12/22/2005US20050282824 Substituted pyrimidines as inhibitors of bacterial type III protein secretion systems
12/22/2005US20050282821 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
12/22/2005US20050282809 Heteroaryl-hydrazone compounds
12/22/2005US20050282805 Five-membered heterocycles useful as serine protease inhibitors
12/22/2005US20050282801 Novel phenantridine analogues and uses thereof
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005CA2569883A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
12/22/2005CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
12/22/2005CA2568451A1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/22/2005CA2567835A1 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
12/22/2005CA2566525A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents
12/22/2005CA2561831A1 Polycyclic pyrazines as potassium ion channel modulators
12/22/2005CA2529445A1 Melanocortin-4 receptor binding compounds and methods of use thereof
12/21/2005EP1607389A1 4-protected-amino-2-substituted-1,2,3,4-tetrahydroquinolines as intermediates for CETP inhibitors
12/21/2005EP1606276A1 Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates
12/21/2005EP1606268A1 Heterocyclic kinase inhibitors
12/21/2005EP1606267A1 Pyrazine compounds as transforming growth factor (tgf) inhibitors
12/21/2005EP1606266A2 Chemical compounds
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1406896B1 Atereoselective method for the preparation of nucleoside analogues
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1395555B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1307445B1 Benzofuran derivatives and their use as antibacterial agents
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005CN1709890A Organic sulfur compound containing piperidine structure, its preparation and use
12/21/2005CN1709870A Optical-purity N',N'-dibasic prolyl hydrazine compound, and its preparing method and use
12/21/2005CN1232513C 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it
12/21/2005CN1232505C Substituted sulfamide (thio) carbonyl compounds
12/20/2005US6977265 Piperidine CCR-3 receptor antagonists
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977258 Antiinflammatory agents; cardiotonic agents; rheumatic diseases
12/20/2005US6977256 Compounds and compositions as cathepsin S inhibitors
12/20/2005CA2338206C High affinity ligands for nociceptin receptor orl-1
12/20/2005CA2302412C Aminoalkylphenol derivatives and related compounds
12/20/2005CA2273303C Thienylsulfonylamino(thio)carbonyl compounds
12/20/2005CA2233560C Sulfonamide inhibitors of matrix metalloproteinases
1 ... 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 ... 523